Transcript Highlights:

• So additionally, starting in 2023, we partnered with the CDC and Brandeis on an in-depth investigation
• So earlier, I mentioned an in-depth investigation with the CDC.
• So earlier, I mentioned an in-depth investigation with the CDC called an Epi-Aid, which was done with
• The CDC Epi-Aid is an epidemiological investigation partnership in which the CDC employs field epidemiologists
• We jointly conducted an investigation with CDC, Brandeis, and community partners in 2023 to 2024.

Keywords: 995, all

Summary: The Special Commission on xylazine held its first meeting, with House Chair Mindy Domb and Senate Co-Chair John Keenan outlining the commission’s charge and a proposed work plan. The commission is tasked with studying the public health and safety impacts of xylazine in the illicit drug supply, including whether it should be scheduled as a controlled substance, how to regulate its production and distribution, and how to improve outreach and treatment for people exposed to it. Members were told the report deadline had been extended to March 30, 2026, and staff proposed a series of public hearings and working groups leading to a final report. The meeting also included attendance, packet materials, and procedural planning. The first major testimony came from BSAS Director Deirdre Calvert, who described xylazine’s appearance in Massachusetts drug supply data, the state’s public health alerts, and DPH’s partnership with Brandeis, CDC, and harm reduction organizations. She emphasized four priorities: reducing stigma and discrimination in health care, expanding self-directed wound care support and coverage for supplies, expanding access to drug checking and test strips, and supporting low-barrier services such as mobile vans and drop-in centers. Commission members asked about first responder awareness, medical education, and whether harm reduction services might face federal restrictions; Calvert said misinformation remains a problem and noted ongoing training efforts, including collaboration with public safety agencies. Several other speakers reinforced the need for low-barrier care and drug checking. Dr. Raghini Jala, an infectious disease and addiction medicine physician, said xylazine has become a common component of the unregulated opioid supply and urged support for rapid-response education teams, community-based drug checking, and better hospital and detox protocols for xylazine withdrawal and wounds. Recovery coach Alan Young testified from lived experience, describing severe wounds, fear of inadequate withdrawal treatment in emergency settings, and the value of mobile care vans that can provide methadone, buprenorphine, and wound care in the community. Dr. Sarah Wakeman echoed the need for naloxone, rescue breathing, low-threshold treatment, and non-stigmatizing health care settings, while Sarah Macon of the Boston Public Health Commission described Boston’s harm reduction and drug checking work, including on-site testing, wound care, and a decline in opioid mortality. Tracy Green of the Massachusetts Drug Supply Data Stream explained that xylazine has declined in recent samples while metatomidine is rising, said drug checking is increasingly used but still not enough, and argued for more funding, staffing, and statewide access to real-time drug checking and harm reduction services.

Transcript Highlights:

• If you do check the CDC schedule, you will see the CDC schedule itself. I'm a grandma.
• If you do check the CDC schedule, you will see the CDC schedule itself. I'm a grandma.
• If you do check the CDC schedule, you will see the CDC schedule itself. I'm a grandma.
• If you do check the CDC schedule, you will see the CDC schedule itself. I'm a grandma.
• No longer trust the CDC. Thank you.

Keywords: 910, house, all

Summary: The joint hearing opened with House Bill 1462 on crisis services. Testimony from the Department of Law Enforcement, the Community Alliance on Prisons, and the Department of Health supported expanding behavioral health crisis services as an alternative to arrest or incarceration. Witnesses said additional crisis sites would help divert people in mental health crisis to appropriate care, and the Department of Health described its current crisis center in Ewa, including the need for renovations such as a padded room and the time required to get the facility operational. In response to questions, the department estimated the Ewa center’s budgeted cost at about $4.3 million, not including rent or startup repairs, and said a second site’s cost would depend on whether it was freestanding or attached to an existing facility. The committee then heard House Bill 700 on cognitive assessments. The Executive Office on Aging supported the bill’s intent but asked that it be amended to make assessments optional rather than mandated, to pilot the program first, and to allow flexibility in handling HIPAA-protected data. SHPDA also supported the measure but said it should not be mandatory and suggested that payers reimburse for assessments when requested by patients, families, or physicians. The Alzheimer’s Association and caregivers strongly supported standardizing cognitive assessments to improve early detection and access to newer treatments, while noting the existing opt-out provision. The Hawaii State Council on Developmental Disabilities supported the bill but asked that the age 65 threshold be removed because cognitive decline can begin much earlier for people with Down syndrome, autism, traumatic brain injury, stroke, and related conditions. In response to a question, the Office on Aging said a pilot project could likely be done for about $150,000, with data security being the main added cost. The final bill discussed was House Bill 237 on peer support programs. Testimony from Family Hui Hawaii, Early Childhood Action Strategy, peer support workers, and families described peer-to-peer programs as a cost-effective way to reduce isolation, strengthen families, and provide long-term community support. Speakers said these programs help parents and caregivers navigate crises, child welfare involvement, addiction recovery, and other challenges, and can have lasting benefits for children’s development and family stability. Several witnesses tied the bill to broader state goals, including infant and early childhood mental health, trauma-informed care, and child welfare reform. Written testimony from about a dozen organizations and individuals was also noted in support.

Transcript Highlights:

• The CDC is a big one.
• Strokes, according to the CDC, stroke is the leading cause of death among men.
• Cardiovascular health, according to the CDC...
• Obesity, according to the CDC, one in three, four men... Are overweight.
• According to the CDC, 46% of men suffer with obesity in the U.S.

Keywords: U.S. House of Representatives Floor Proceedings on Monday, June 9, 2025, 1012, house, all

Transcript Highlights:

• According to the latest CDC report, the current prevalence rate for autism spectrum disorders is 1 in
• According<00:01:16.240> to<00:01:16.320> the<00:01:16.560> latest<00:01:16.960> CDC
• According to the latest CDC disorder.
• According to the latest CDC report,<00:01:18.400> the<00:01:18.720> current<00:01:18.960

Keywords: Meeting Start 00:00:00 Roll Call 00:00:01 SB 69 Discussion 00:00:30 SB 69 Vote 00:05:52, 958, all

Summary: The committee met with a quorum and took up only one item: Senate Bill 69, sponsored by Senator Julie Adams. The bill would create an autism spectrum disorder trust fund in the state treasury, allow taxpayers to contribute a portion of their individual income tax refunds to the fund, and authorize additional grants, contributions, and appropriations. Senator Adams said the fund is intended to support autism spectrum disorder research and services in Kentucky, administered by the Cabinet for Health and Family Services with grants awarded through the advisory council on autism spectrum disorders based on a statewide needs assessment. She also noted the bill includes an emergency clause. During questions, Senator Boswell confirmed the tax refund contribution option would be available on both paper and electronic returns. Senator Funky From asked how families would access services, and Senator Adams explained that providers would apply for grants to the trust fund, which would then review and award funding if the proposal was deemed a good use of the money. No outside testimony was presented; a signed-up witness from the Russell County Fiscal Court did not speak. The committee then moved the bill, with Senator Boswell making the motion and Senator Neil seconding it. The roll call resulted in 12 yes votes and no nays, and Senate Bill 69 passed the committee with a favorable expression. The committee then adjourned.

Transcript Highlights:

• safety uh uh actually you can check CDC safety uh uh actually you can check CDC vies<03:37:49.920
• cation so basically CDC cation so basically CDC virus<03:38:46.439> database<03:38:47.120
• <03:40:12.640> virus basically CDC virus basically CDC virus database<03:40:15.000> is<
• looking at the this it looks like a CDC looking at the this it looks like a CDC report<03:56:45.680
• federal Partners primarily the CDC federal Partners primarily the CDC although<03:58:40.960>

Keywords: 1189, house, all

Transcript Highlights:

• The CDC was unable to give us a straight answer.
• The CDC was unable to give us a straight answer.
• The CDC, as well as our counterparts in the DHHS Division, were consulted.
• The CDC was unable to give us a straight answer.
• The CDC was unable to give us a straight answer.

Keywords: 1191, senate, all

Transcript Highlights:

• First, the CDC in that study did not include infants, although they include infants in every other study
• , 16-, and 17-year-olds when they didn't include those age groups for other safety studies with the CDC
• When you accounted for those discrepancies and First, the CDC in that study did not First, the CDC in
• <00:28:24.320> When<00:28:24.559> you safety studies with the CDC.
• When you safety studies with the CDC.

Keywords: Convene 00:00 Senate Message 04:41 Calendar/2nd Readings 05:37 Orders of the Day 06:14 HB 312 06:41 Interrupted Stream 38:41, 958, all

Summary: The House convened with an invocation focused on the approaching storm and the need to check on neighbors, first responders, hospitals, and vulnerable residents. A quorum was established, absent members were excused, the rules were suspended for co-sponsorship and vote modification filings, and the journal from Thursday, January 22, 2026 was approved. The clerk also reported Senate passage of SB 13, 22, 46, 51, and 90 and requested concurrence. Under orders of the day, HB 258 was recommitted to the Transportation Committee. The chamber then took up HB 312, an act relating to concealed firearms and deadly weapons, which would create a provisional concealed carry license for law-abiding 18- to 20-year-olds. The sponsor argued the bill restores equal treatment for adults, aligns Kentucky with other states, and imposes training and background-check requirements. Supporters said the Second Amendment applies to this age group, that military service and other adult responsibilities are already entrusted to them, and that the bill would not change prohibited locations for firearms. Opponents argued the measure would increase gun violence and public safety risks, citing concerns from school district police, SROs, and empirical research about firearm-related assaults, homicides, and brain development in young adults. They emphasized that concealed weapons reduce visibility for parents, schools, and law enforcement and pointed to local youth-violence prevention efforts in Lexington as progress that could be undermined. Supporters countered that defensive gun use is common, that the CDC and other studies overstate gun harms, and that the bill is about constitutional rights rather than hunting or alcohol analogies. The transcript provided does not include the final vote on HB 312.

Transcript Highlights:

• And I think, you know, getting to that CDC.
• The CDC continues to recommend that the solution for that is a comprehensive, evidence-based, statewide
• Right now, the CDC grant terms end in October, so the CDC has been providing tobacco control grant dollars
• the states that I've been in contact with through some of the partnerships that we had through the CDC
• contracted with, there's just one entity, I think, that showed where there was some monies from the CDC

Transcript Highlights:

• It is also the term that is used by the CDC, and one that we recommend using for clarity purposes.
• It is also the term that is used by the CDC, and one that we recommend using for clarity purposes.
• It is also the term that is used by the CDC, and one that we recommend using for clarity purposes.
• It is also the term that is used by the CDC, and one that we recommend using for clarity purposes.
• It is also the term that is used by the CDC, and one that we recommend using for clarity purposes.

Keywords: 912, senate, all

Summary: The Health and Human Services committee hearing opened with notice that the meeting was being streamed and could reconvene later if technical problems forced an abrupt end. The chair also announced a one-minute testimony limit and proceeded through several bills, taking mostly written and oral support testimony and asking limited questions. No votes were taken in the portion provided. HB 1626, relating to youth penalties, drew strong support from the Office of Hawaiian Affairs, youth advocates, the ACLU, the Department of Education, and others. Testifiers said financial sanctions on youth are ineffective, disproportionately burden Native Hawaiian youth, and function as poverty penalties; they urged replacing fines with community service, restorative practices, and ʻāina-based programs, and eliminating uncollectible legacy debt. The chair moved on after no member questions. HB 1643, relating to pharmacy, was discussed with support from the Hawaii Pharmacists Association, Kaiser, the Board of Pharmacy, independent pharmacies, and PBM representatives. Testimony focused on amendment language, audit procedures, HIPAA concerns, and the need for flexibility for small island pharmacies. HB 1668, relating to Medicaid, received broad support from disability advocates and the Department of Human Services; witnesses said CMS had already approved the underlying state plan amendment removing income and asset limits for certain workers with disabilities, but they wanted the protection codified in law to preserve it long term. The chair asked whether codification was necessary and was told it would not be harmful and would help ensure continuity if federal policy changed. The committee then heard HB 1550 on drug paraphernalia and syringe access, with support from Shipta and the Department of Health; testimony emphasized preserving flexibility for the statewide syringe access program to respond to emerging drugs like xylazine. HB 1974, relating to health, was presented as a planning measure for hearing loss; testifiers said Hawaii lacks a comprehensive hearing-loss plan and that the bill would fund a state planning process, not direct services. HB 1858 on vital statistics drew support from clinicians and medical organizations, who said better data on spontaneous fetal deaths is needed and that the term used in the bill is standard medical and CDC terminology. HB 1871 and HB 1966 also received support, with HB 1966’s EMS special fund prompting discussion about the cigarette-tax revenue source; the chair questioned the nexus to EMS, and the Department of Health said the revenue currently funds the special fund and there is no alternative funding stream.

Transcript Highlights:

• The SBA has long served this need through its loan guarantee programs, including the 504 CDC program.
• THE REQUIREMENT FOR STANDARD 504 CDC LOANS.
• Unfortunately, no statutory reporting requirement exists for the 504 CDC loan program.
• UNFORTUNATELY, NO STATUTORY REPORTING REQUIREMENT EXISTS FOR THE 504 CDC LOAN PROGRAM.
• program and provide Congress with the results tailored to the 504 CDC Program's unique features.

Keywords: U.S. House of Representatives Floor Proceedings on Tuesday, January 20, 2026, 1012, house, all

Transcript Highlights:

• safety uh uh actually you can check CDC safety uh uh actually you can check CDC vies<03:37:49.920
• cation so basically CDC cation so basically CDC virus<03:38:46.439> database<03:38:47.120
• <03:39:21.800> virus different vaccines and CDC virus different vaccines and CDC virus database
• <03:40:12.640> virus basically CDC virus basically CDC virus database<03:40:15.000> is<
• looking at the this it looks like a CDC looking at the this it looks like a CDC report<03:56:45.680

Keywords: 928, house, all

Summary: The House Committee on Health, Human Services and Elderly Affairs heard testimony on House Bill 606, as amended, a bill aimed at preventing physicians from denying medically necessary sterilizing or fertility-affecting treatment based on a patient’s age, number of children, marital status, or a doctor’s speculation about future reproductive intentions. Representative Ellen Reed, the sponsor, described the bill as a response to her own long experience with PCOS, heavy bleeding, and repeated refusals by doctors to perform a hysterectomy despite her clear wishes. She said the amendment narrows the bill to medically necessary care, adds definitions for “medical condition” and “appropriate reproductive care,” and removes earlier provisions about voluntary sterilization referrals. She also said the bill does not target religious objections, and that doctors could still refuse for medical, payment, or existing religious reasons not addressed by the bill. Committee members asked about religious freedom, informed consent versus waivers, and the scope of the new definitions. Reed responded that religion was not added to the list of prohibited reasons for denial, and that the amendment is intended to protect doctors when patients sign informed consent or waivers. She explained that “appropriate reproductive care” includes procedures such as hysterectomy, oophorectomy, orchiectomy, salpingectomy, and endometrial ablation, and that the bill now focuses on medically necessary treatment rather than elective sterilization. She said the change was intended to make the proposal narrower and more tailored after earlier concerns. Several witnesses supported the bill with personal accounts of being denied hysterectomies or other procedures despite serious symptoms. Representative Lauren Selig described a decade-long effort to obtain a hysterectomy after years of cycle problems and migraines, saying doctors dismissed her concerns and treated her symptoms as normal. Jade Flad also testified in support, saying she had long been told to simply endure her cycle problems and noted that her husband was offered a vasectomy without similar barriers. The sponsor said online support was strong and that there was little or no written opposition testimony. No vote or final committee action was taken during the portion of the hearing provided.

Transcript Highlights:

• It's not part of the CDC that I... I know the CDC defunding did affect the rare disease community.
• <00:59:33.839> that it's not part of the CDC that it's not part of the CDC that I<00:59:35.680
• okay Senator AER I know the CDC okay Senator AER I know the CDC defunding<00:59:44.400> did
• It's not me; it's a public letter to the CDC.
• It's not me; it's a public letter to the CDC.

Keywords: 1187, senate, all

Transcript Highlights:

• This is the CDC recommendation for all healthy children.
• The one-size-fits-all CDC vaccine schedule is flawed.
• The one-size-fits-all CDC vaccine schedule is flawed.
• Investigative journalists pored over the emails from the CDC.
• And also that pharma has undue influence over the FDA and the CDC.

Keywords: 995, all

Summary: The Joint Committee on Public Health held a hearing on several vaccination-related bills, including proposals to eliminate non-medical or religious exemptions for school immunizations (notably H. 2554 and S. 1557), a bill to require or improve reporting and administration of immunization data and exemptions (described as the Community Immunity Act, S. 1618), and H. 2431, which would prohibit COVID-19, mRNA, or gene-altering vaccine requirements. The committee also heard testimony on H. 2463, which would classify funeral directors as public health workers for vaccine-priority purposes during emergencies. The chair reviewed testimony rules and repeatedly asked speakers to keep comments orderly and brief so the committee could hear as many people as possible. No votes were taken during the hearing. Testimony on H. 2554 and S. 1557 was sharply divided. Pediatricians, infectious disease specialists, public health advocates, and groups such as the Massachusetts Chapter of the American Academy of Pediatrics, Massachusetts Medical Society, March of Dimes, Massachusetts Families for Vaccines, and several parents supported eliminating religious exemptions, arguing that vaccination protects medically vulnerable children and adults, improves herd immunity, and helps prevent outbreaks of measles, pertussis, and other diseases. They cited local school data showing pockets of lower coverage and incomplete reporting, and several speakers referenced outbreaks in other states and the need for stronger, more consistent reporting and exemption management. Opponents argued the bills would infringe on religious freedom and parental rights, force families to choose between faith and education, and unfairly target a small number of families; some also said Massachusetts already has high vaccination rates and that the real issue is incomplete data or the gap population rather than religious exemptions. H. 2431 drew testimony from supporters who said COVID-era mandates caused job losses, privacy concerns, and harm, and that the bill would prevent future requirements for COVID, mRNA, or gene-altering vaccines in schools, workplaces, and public settings. Supporters described personal experiences with alleged vaccine injury or mandate-related hardship. H. 2463 was supported by the Massachusetts Funeral Directors Association, which argued funeral directors work in infection-facing settings and should be eligible for vaccine priority during public health emergencies. The hearing featured extensive public testimony but no committee action beyond hearing the bills and taking questions from members.

Transcript Highlights:

• The CDC collects some of this information in state-specific ways. Is there some holes in that data?
• The CDC collects some of this information in state-specific ways. Is there some holes in that data?
• The CDC collects some of this information in state-specific ways. Is there some holes in that data?
• The CDC collects some of this information in state-specific ways. Is there some holes in that data?
• CDC collects some of this information in state-specific ways. Is there some holes in that data?

Keywords: 958, all

Summary: The Senate Standing Committee on Health Services met with a quorum, first taking up referred administrative regulations. One regulation was deferred, and two others were noted as deficient; with no one wishing to speak, the committee treated the regulations as reviewed. The committee then heard Senate Bill 13 from Chairman Meredith, which would reduce the number of Medicaid managed care organizations from five to three. Meredith argued the bill would reduce administrative burden, improve oversight, help rural providers, and potentially lower costs for families and the Medicaid program. Senators Berg, Herron, and Douglas asked about data, patient impact, network adequacy, and prior authorization burdens; Meredith said the effect on patients would be indirect through better access and less administrative delay. The committee approved a committee substitute and passed SB 13 favorably on a 10-0 vote. The committee next considered Senate Joint Resolution 26, presented by Senator Richardson and Kentucky Pharmacists Association Executive Director Ben Mudd. The resolution asks the Department of Medicaid Services to provide data and cost analysis on paying pharmacists fairly for clinical services already within their scope of practice under Medicaid and KCHIP. Supporters said pharmacists can improve access, especially in rural areas, by providing services such as medication therapy management, chronic disease management, and preventive care, and that the resolution is intended to gather information before any future bill. Senator Douglas questioned whether expanded pharmacy duties have actually improved access or outcomes and whether there is published data; Mudd said the Board of Pharmacy tracks use of protocols but that more data is needed. The committee approved the resolution by roll call, with all members voting aye. At the end of the meeting, Chairman Meredith announced that Senate Bill 27 would be heard for discussion only and not acted on that day so members could review it further. Senator Brandon Storm introduced SB 27, which would create a Kentucky Parkinson’s disease research registry, and noted that a Michael J. Fox Foundation representative could not attend because of a winter storm; her letter was included in the packet. Storm said the registry is intended to support research and policy by tracking Parkinson’s disease in Kentucky, citing national prevalence and cost figures. No vote was taken on SB 27 during this meeting.

Transcript Highlights:

• It's a slow process, and that's even at the CDC level nationally.
• The information that we send into CDC is actually North Dakota's information.
• That is the CDC definition of maternal mortality.
• The MMRC this year, the CDC this year, for the first time, presented two bodies of information.
• CDC, we talk about de-identification. They require that. We looked at like states.

Summary: The committee first approved the minutes and then heard a detailed annual presentation from Dr. Thomas Arnold, chair of the Maternal Mortality Review Committee, on maternal mortality trends and review findings. He explained the committee’s structure, the de-identified review process, and the distinction between pregnancy-associated and pregnancy-related deaths. He said national maternal mortality has declined from its 2021 peak, but mental health conditions, substance use, overdose, suicide, cardiovascular disease, hemorrhage, infection, and embolism remain major causes. He emphasized that many deaths are preventable, with especially high rates among non-Hispanic Black women and in the American Indian/Alaska Native population, and noted that a large share of deaths occur after 42 days postpartum. Committee members asked about suicide, domestic abuse, pregnancy testing in unexplained deaths, and the role of home births and midwife training. Dr. Arnold said the committee is adding a caseworker, exploring post-mortem pregnancy testing in suspicious cases, and working with coroners and forensic officials; he also said home births and untrained midwifery pose safety concerns and that better public education and facility-based care are important. The committee then heard from State Fire Marshal Dr. Matt Clark on cigarette ignition propensity standards and fire prevention. He recommended updating North Dakota’s cigarette ignition legislation to the current national standard and also considering legislation requiring fast-breakaway oxygen tubing, citing fatal fires involving smoking around home oxygen. He explained that his office verifies manufacturer testing and maintains certification for cigarettes sold in the state, but does not itself conduct the testing. Members asked about implementation, cost, and whether the standards apply in tribal communities; Clark said he would follow up with cost information and additional details, and that he had not seen evidence of a major issue on tribal lands but would look further. Christine Greff of the Department of Health and Human Services presented the North Dakota Stroke System of Care report. She described the statewide network of two comprehensive stroke centers, four primary stroke centers, and 30 acute stroke-ready hospitals, along with the stroke registry and quality-improvement efforts. She reported that most strokes are ischemic, that the median stroke patient age is 71.5, and that common risk factors include hypertension, dyslipidemia, obesity, and diabetes. She highlighted improvements in door-to-CT, thrombolytic treatment times, dysphagia screening, EMS pre-notification, and interfacility transfer performance, and said new priorities include hemorrhagic stroke quality measures and standardized EMS stroke screening tools. Members asked about the VA hospital’s participation, and Greff said she would pursue outreach. After a break, the committee heard testimony from Taha Khan of Vertex Pharmaceuticals as part of the prior authorization study, focused on non-opioid pain treatment. He argued that prior authorization can delay access to acute pain treatment and may push patients toward opioids, especially in the critical 24- to 72-hour post-discharge window. He cited data showing that even short opioid exposure can increase the risk of long-term use and said prior authorization is often a barrier for physicians and patients. Khan recommended open access with a quantity limit rather than prior authorization, suggesting a 14-day limit supported by the product’s data and an episode-of-care approach. Members asked about dental use, payer discussions, and cost; he said the product’s wholesale acquisition cost is about $16.10 per tablet, with patient assistance available, and that he would follow up on payer and comparison-cost questions.

Transcript Highlights:

• We have mandatory reporting to the CDC.
• The CDC, we have required reporting to the CDC of communicable diseases, and there has to be certain
• Um, the issue really is dealing with it's on the CDC side with some of the contractors that they've hired

Keywords: 924, joint, all

Transcript Highlights:

• earlier presentation, can you talk a little bit about whether you are having any issues with your CDCs
• Our Child Development Center (CDC), for a while there, whenever the current administration did the bring
• So our CDC, but we're good. We've been able to hire because there are non-appropriated funds.
• We actually have quite a few Holloman residents that are bringing their kids to our CDC because we have
• We don't have any issues with the CDC, our Child Development Center, or our school age services.

Transcript Highlights:

• The CDC... ...on even though they were FDA approved initially.
• And so I'm on the board of another nonprofit that gave a FOIA request to the CDC for the V-SAFE data,
• kind of oversight exists for genetic technologies like mRNA, and have any agencies like the FDA or CDC
• The CDC would then collate it in a form that maybe wasn't as useful to us, send it back.
• I think that we depend too much on data that is being accumulated and stored in another state, the CDC

Bills: HB18, HB37, HB 116, HB388, HB879, HB913, HB 1151, HB2216, HB2358, HB2809, SB577, SB1590, SB1782, SB1887, SB2744

Keywords: rural health, hospital funding, healthcare access, mental health services, financial stability, perinatal bereavement, healthcare, hospital training, bereavement support, maternal care, fetal demise, stillbirth, neonatal death, parent-child relationship, involuntary termination, family law, child welfare, child protection, HB 388, HB388

Summary: The committee first reopened testimony on House Bill 2216, which would strengthen child welfare requirements by expanding “active efforts” to help families avoid removal and support reunification, while also raising standards related to removals and terminations. Supporters from child welfare and family defense groups said the bill would better protect families and align Texas more closely with ICWA-style principles, but several warned it would require significant new funding, staffing, and community services such as mental health care, housing, child care, and substance use treatment. The committee then left HB 2216 pending. The committee next heard Senate Bill 1782, aimed at boarding and group homes. Senator Miles said the bill closes enforcement gaps left by prior law by requiring retention of background-check records and creating misdemeanor penalties for failing to conduct or keep them, or for knowingly hiring people with serious convictions. Harris County sheriff’s investigators testified in support, describing illegal boarding homes, operators who evade permits and background checks, and exploitation of vulnerable residents; the bill was left pending. The committee also took up Senate Bill 481 on emergency preparedness for nursing facilities and assisted living facilities, adopted a new committee substitute that softened some requirements and removed the fiscal note, and left the bill pending. The committee then heard House Bill 388, which would require the Texas Department of Insurance to create a single standardized coordination-of-benefits form for dual health plans to reduce errors and surprise bills; it was left pending. Senate Bill 1590 would move paternity registry searches for adoptions to an electronic process with a 10-day target, and House Bill 2809 would track child suicide attempts in managing conservatorship and require related reporting and parental notice; both were left pending. The committee also heard Senate Bill 1887, which would prohibit administering mRNA-containing products for immunization for 10 years, with exceptions for cancer and genetic disorders. Supporters argued the bill was needed for safety, informed consent, and medical freedom, while opponents from the medical, research, and public health communities said mRNA vaccines are well-studied, save lives, and that the bill would harm access, research, and Texas’s biotech economy. The bill remained under discussion as testimony concluded.

Transcript Highlights:

• But the CDC when they made prevented.
• But the CDC when they made the<00:28:02.080> assertion<00:28:02.480> that<00:28:02.640>
• First,<00:28:10.240> the<00:28:10.480> CDC<00:28:10.960> in<00:28:11.200> that
• <00:28:25.279> When<00:28:25.520> you safety studies with the CDC.
• When you safety studies with the CDC.

Keywords: The live stream for the House Chambers was interrupted and this version was recovered from backups and should contain the complete Legislative Session. Convene 00:00:00 Senate Message 00:04:40 Calendar/2nd Readings 00:05:38 Orders of the Day 00:06:14 HB 312 00:06:42 Motions, Petitions, and Communications 01:11:07 Introduction of New Bills and Resolutions 01:13:24 Recess for ConC and Rules Meeting 01:14:30 ConC/Rules Report 01:19:42 Adjournment 01:21:18, 958, all

Summary: The House convened, received the invocation and Pledge of Allegiance, established a quorum with 89 members present, excused absent members, and suspended rules to allow co-sponsorships and vote modifications. The chamber approved the prior day’s journal and received notice that the Senate had passed SB 13, 22, 46, 51, and 90 and requested concurrence. On second reading, HB 134 (sexual assault nurse examiners), HB 168 with HCS 1 (voting under the influence), and HR 7 (recognizing guiding principles of elections in Kentucky) were reported. The House also recommitted HB 258 to the Transportation Committee and took up HB 312 for third reading and passage. HB 312, relating to concealed firearms and deadly weapons, drew the bulk of the debate. The sponsor argued the bill would allow law-abiding 18- to 20-year-olds to obtain a provisional concealed carry license, saying they are adults in other respects, the Second Amendment protects their right to bear arms, and Kentucky should align with other states. Supporters framed the measure as a constitutional rights issue and cited defensive gun use statistics, while one member argued the root problem is family upbringing rather than guns. Opponents said the bill would increase risks in schools and public spaces, pointed to concerns from school district police and SROs, and cited research linking younger age groups and loosened carry laws to higher firearm violence; they also argued the bill would make communities less safe and that no one’s rights would be taken away by voting no. The sponsor said no stakeholder had expressed opposition and clarified the bill would not change where firearms are permitted. The transcript provided does not include the final vote on HB 312.

Transcript Highlights:

• Why not allow that to happen here in the same way that it happened at the CDC as opposed to go for a
• Uh, now, uh I think that the new recommendations from the CDC allow for that, and yet some uh states
• Why not allow that to happen here in the same way that it happened at the CDC as opposed to go for a
• Uh, now, uh I think that the new recommendations from the CDC allow for that, and yet some uh states
• Why not allow that to happen here in the same way that it happened at the CDC as opposed to go for a

Keywords: 1189, house, all